Replies to post #17018 on GeneSYS ID Inc fka GNID

[Penny Stocks 2.0]

Investors are holding on because we were all told an Investment banker/deal announcement was supposedly coming. Then silence transpired, then Tweets came...then the 10-k come out referencing EVERYTHING that's transpired up to now, but still nothing, absolutely nothing but guess work as to any type or size of deal or backing or anything to do with a Blue Chip Investment banker. NOTHING WHAT SO EVER.

Why is the most important aspect to the future of RXSF and its Shareholders still missing.

I heard December, nothing.
I heard January, nothing.
I heard March, nothing.

I think it's coming BUT WHEN...Shareholders need comfort, No?

How can a company up list this year when we are still obviously seeking the $$!!

[HokieHead]

We get a 1:200 split and then the company does this? Are you serious? You think this is perfectly fine?



On March 10, 2016 Auctus Fund LLC converted $50,995.78 of the principal and interest on its convertible promissory note into a total of 97,991 shares of our common stock, subject to the terms of a leak-out agreement.

On February 12, 2016 Auctus Fund LLC converted $13,000 of the principal on its convertible promissory note into a total of 25,000 shares of our common stock, subject to the terms of a leak-out agreement.

On February 1, 2016, holders with an aggregate of 100 shares of the Series B preferred stock converted their shares into 10,000,000 shares of our common stock.

On January 19, 2016 Auctus Fund LLC converted $13,260 of the principal on its convertible promissory note into a total of 20,000 shares of our common stock, subject to the terms of a leak-out agreement.

On January 4, 2016 Kodiak Capital Group converted $11,832.10 of the principal and interest of LG Capital’s convertible promissory note into 22,754 shares of our common stock.

On January 4, 2016 we entered into a website and marketing agreement with IR3Point0 LLC. As compensation for the agreement IR3 will receive $1,000 per month as well as a total of 2,000 shares of restricted stock.

On December 30, 2015, we issued a total of 10,858 shares of our common stock to our five Directors as compensation for their services in lieu of cash payment

On December 30, 2015, we issued a total of 32,750 shares of our common stock to a total of 3 consultants.

On December 30, 2015 Kodiak Capital Group converted $10,000 of the principal of LG Capital’s convertible promissory note into 19,230 shares of our common stock.

On December 24, 2015 Kodiak Capital Group converted $5,000 of the principal of LG Capital’s convertible promissory note into 9,615 shares of our common stock.

On December 16, 2015, we issued 2,973 shares of our common stock to a consultant.

On December 10, 2015, we issued 828 shares of our common stock to a consultant.

On December 1, 2015, we issued 5,000 shares of or commons stock to a consultant.

On November 30, 2015, we issued 1,727 shares or our common stock to a consultant.

On November 11, 2015, we entered into a binding letter of intent to purchase all right, title and interest to patent number 7,806,852. As part consideration, we agreed to pay to the seller $100,000 in the form of warrants to purchase shares of our common stock.

On November 9, 2015, we entered into a consulting agreement with West Coast Capital Consultants. As compensation the consultant was issued 16,500 shares of common stock under the agreement.

On November 2, 2015, we entered into a consulting agreement with Pentony Enterprises LLC to provide social media services. As compensation, the consultant will receive $18,000 payable in shares of our common stock as well as monthly cash compensation of $600. On December 2, 2015, we issued 5,652 shares of our common stock to Pentony Enterprises, LLC, as per the compensation agreed under his November 2, 2015 agreement.

On October 21, 2015, we issued 5,000 shares of our common stock to a consultant.